日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Unraveling the indolence of papillary thyroid carcinoma: an exploratory study on B-cell subsets based on genetic predisposition and tumor immunity

揭示乳头状甲状腺癌惰性机制:基于遗传易感性和肿瘤免疫的B细胞亚群探索性研究

Wang, Pei; Dong, Zhizhong; Peng, Xing; Zhou, Cong; Cheng, Ruochuan; Liu, Wen

Single-cell transcriptomics analysis reveals that the tumor-infiltrating B cells determine the indolent fate of papillary thyroid carcinoma

单细胞转录组学分析表明,肿瘤浸润的B细胞决定了乳头状甲状腺癌的惰性命运。

Li, Chunmei; Wang, Pei; Dong, Zhizhong; Cao, Weihan; Su, Yanjun; Zhang, Jianming; Zhao, Shuyan; Wang, Zhiyuan; Lei, Zi; Shi, Li; Cheng, Ruochuan; Liu, Wen

Factors influencing the quality of life in survivors of differentiated thyroid cancer based on patient-reported outcomes: a single-center cross-sectional study

基于患者报告结局的分化型甲状腺癌幸存者生活质量影响因素:一项单中心横断面研究

Dong, Zhizhong; Zhan, Xiangxiang; Liu, Wen; Rao, Dewei; Yang, Miao; Peng, Ying; Su, Yanjun; Cheng, Ruochuan

Videos on YouTube, Bilibili, TikTok as sources of medical information on Hashimoto's thyroiditis

YouTube、Bilibili、TikTok 等平台上的视频是获取桥本甲状腺炎相关医疗信息的重要来源。

Wang, Shiqi; Jia, Siyu; Su, Yanjun; Cheng, Ruochuan

Glutamate activates the MAPK pathway by inhibiting LPAR1 expression and promotes anlotinib resistance in thyroid cancer.

谷氨酸通过抑制 LPAR1 表达激活 MAPK 通路,从而促进甲状腺癌对安罗替尼的耐药性

Liu Bin, Peng Ying, Su Yanjun, Diao Chang, Cha Liansheng, Cheng Ruochuan

Anlotinib inhibits c-MET and ITGA2 in the treatment of anaplastic thyroid carcinoma.

安罗替尼通过抑制 c-MET 和 ITGA2 来治疗未分化型甲状腺癌

Zhao Shunshun, Meng Mingyao, Cheng Ruochuan, Zhang Min, Liu Chuanyuan, Meng Qiuyu, Yang Tingting, Huang Haohan, Liu Bin, Wang Xiaodan, Su Yanjun

Development and validation of a necroptosis-related gene signature for predicting prognosis and immune infiltration in papillary thyroid cancer.

开发和验证坏死性凋亡相关基因特征,用于预测乳头状甲状腺癌的预后和免疫浸润。

Wang Shiqi, Zhan Xiangxiang, Peng Ying, Rao Dewei, Yang Miao, Su Yanjun, Cheng Ruochuan

Trends of the prevalence rate of central lymph node metastasis and multifocality in patients with low-risk papillary thyroid carcinoma after delayed thyroid surgery

低危乳头状甲状腺癌患者延迟甲状腺手术后中央淋巴结转移和多灶性病变发生率的变化趋势

Wang, Pei; Dong, Zhizhong; Zhao, Shuyan; Su, Yanjun; Zhang, Jianming; Ma, Yunhai; Diao, Chang; Qian, Jun; Cheng, Ruochuan; Liu, Wen

Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial

安罗替尼治疗局部晚期或转移性放射性碘难治性分化型甲状腺癌:一项随机、双盲、多中心 II 期试验

Chi, Yihebali; Zheng, Xiangqian; Zhang, Yuan; Shi, Feng; Cheng, Ying; Guo, Zhuming; Ge, Minghua; Qin, Jianwu; Zhang, Jiewu; Li, Zhendong; Zhou, Xiaohong; Huang, Rui; Chen, Xiaohong; Liu, Hui; Cheng, Ruochuan; Xu, Zhengang; Li, Dapeng; Tang, Pingzhang; Gao, Ming

Safety and effectiveness of carbon nanoparticles suspension-guided lymph node dissection during thyroidectomy in patients with thyroid papillary cancer: a prospective, multicenter, randomized, blank-controlled trial

碳纳米颗粒悬浮液引导下淋巴结清扫术在甲状腺乳头状癌甲状腺切除术中的安全性和有效性:一项前瞻性、多中心、随机、空白对照试验

Zhao, Jingzhu; Wang, Junyi; Cheng, Ruochuan; Qin, Jianwu; Ai, Zhilong; Sun, Hui; Guo, Zhuming; Zhang, Xiaohua; Zheng, Xiangqian; Gao, Ming